News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Ezose Sciences, Inc. in New Agreement with Merck & Co., Inc. (MRK) to Advance Glycan Biomarker Discovery in Diabetes



12/9/2011 6:41:52 AM

PINE BROOK, N.J.--(BUSINESS WIRE)--Ezose Sciences Inc. announced today that it has entered an agreement with Merck, through a subsidiary, to collaborate on biomarker discovery research in the field of diabetes. The collaboration seeks to identify glycans, the complex carbohydrate component of glycoproteins, which can play a role in health and disease.

Read at BioSpace.com


comments powered by Disqus
   
Diabetes

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES